Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!
Funded Awards (CDA, DEI) Honorific Awards
Not a member? Anyone with a demonstrated professional interest in gene and cell therapy is invited to join—apply now and earn eligiblity for ASGCT's funded awards.
Join Today!
Supporting ASGCT members who are working toward independence in their gene and cell therapy careers though a robust grants program.
ASGCT will award up to two $100,000 awards to postdoctoral or early-career members from a population underrepresented in the scientific workforce.
The ASGCT Outstanding Achievement Award recognizes an ASGCT Member who has achieved a pioneering research success, a specific high impact accomplishment, or a lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor.
Several Outstanding New Investigators are recognized each year based on their contributions to the field of gene and cell therapy. Investigators from academia, research foundations, government, and industry are all eligible to be nominated for awards.
This honorific award recognizes individuals for their outstanding contributions toward the mentorship, training, education, or support of students, residents, fellows, trainees, or other early career professionals either through formal training programs or through non-traditional means.
Named for the first person to study viral mediated gene therapy for muscular dystrophy in humans, and the principal investigator in the study that led to the FDA approval of Zolgensma to treat SMA, the Jerry Mendell Award for Translational Science recognizes the extensive work required to bring gene and cell therapies to clinical trial. Supported by Dr. Suku and Ann Nagendran
Named for its inaugural co-recipient and tireless gene therapy advocate, the Society’s Sonia Skarlatos Public Service Award recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education, or non-governmental charitable organizations.
This honorific award recognizes individuals, organizations, or other entities for their outstanding contributions toward the Society’s principles and programs advancing diversity, equity, and inclusion.
This honorific award recognizes individuals for their outstanding contributions to ASGCT and their commitment to Society’s mission to advance knowledge, education, and awareness of gene and cell therapy.
NEW in 2023, this award highlights the contributions of leading early-career authors to the Molecular Therapy family of journals.
The ASGCT Catalyst Award recognizes an ASGCT member or team of professionals who have had an extraordinary impact on the translation of gene and cell therapies.
Established in 2022, the ASGCT Founders Award recognizes a pioneering contributor to the gene and cell therapy field. It is among the Society’s highest honors and the recipient presents a keynote lecture highlighting their accomplishments that led to the award.
Sept. 25-26, 2025 | Washington, D.C.
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico